Tekscend Photomask Corp.
TSE Prime
¥3,740.00
-5.20%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.32.
- Comfortable interest cover: operating profit covers interest about 15.3 times.
- Return on equity is healthy at 17.2%.
- Return on capital employed is moderate at 13%.
- Net profit margin is strong at 19.3%.
- Current assets comfortably cover current liabilities (current ratio 5.37).
!Watch-points
- Profit growth has been slow over five years (about 4% a year).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreGrey zone
1.87
This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.
Computed without the market-value term.
Piotroski F-ScoreWeak
3 / 4
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 4 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap¥3,716億
Current Price¥ 3,740.00
High / Low¥ 5,290.00 / 2,671.00
Stock P/E14.992383
Book Value¥ 1,230.87
Dividend Yield1.42%
ROCE12.95%
ROE17.20%
Debt to Equity0.32
Current Ratio5.37
P/B Ratio2.0935526
EPS¥ 261.12
PAT Margin19.25%
ICR15.29
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity